Why the study?
The mechanisms underlying the development of dilated cardiomyopathy and heart failure caused by TNNT2 mutations remain incompletely understood.
Does XINB overexpression improve cardiac function and remodeling in TNNT2-ΔK210 mutant models of dilated cardiomyopathy?
Does XINB overexpression improve cardiac function and remodeling in TNNT2-ΔK210 mutant models of dilated cardiomyopathy?
Cardiac-specific overexpression of XINB ameliorates dilated cardiomyopathy remodeling and systolic dysfunction caused by TNNT2-ΔK210 mutation in preclinical models.
XINB overexpression remains preclinical only and should not change practice; leaves open a gene-therapy target in TNNT2-DCM.
TNNT2 mutation is associated with a range of cardiac diseases, including dilated cardiomyopathy (DCM). However, the mechanisms underlying the development of DCM and heart failure remain incompletely understood. In the present study, we found the expression of cardiac XIN protein was reduced in TNNT2 -ΔK210 hESCs-derived cardiomyocytes and mouse heart tissues. We further investigated whether XIN protects against TNNT2 mutation-induced DCM. Overexpression of the repeat-containing isoform XINB decreased the percentage of myofilaments disorganization and increased cell contractility of TNNT2 -ΔK210 cardiomyocytes. Moreover, overexpression of XINB by heart-specific delivery via AAV9 ameliorates DCM remodeling caused by TNNT2 -ΔK210 mutation in mice, revealed by partially reversed cardiac dilation, systolic dysfunction and heart fibrosis. These results suggest that deficiency of XIN may play a critical role in the development of DCM. Consequently, our findings may provide a new mechanistic insight and represent a therapeutic target for the treatment of idiopathic DCM.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: